3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
57
Observational
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
2
Interventions
Sunitinib
16
exemestane
11
Afatinib
11
palbociclib
10
Rituximab
10
Bevacizumab
10
Erlotinib Hydrochloride
9
Leuprolide
8
Radiotherapy
7
Drug Therapy
7
Axitinib
7
avelumab
6
Letrozole
6
Capecitabine
6
Blood Specimen Collection
6
enzalutamide
5
Trastuzumab
5
Surveys and Questionnaires
5
Standard of Care
5
Docetaxel
5
Aromatase Inhibitors
5
lorlatinib
4
Specimen Handling
4
Radiation
4
Mammography
4
Crizotinib
4
Anastrozole
4
Abiraterone Acetate
4
temsirolimus
3
talazoparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Has results
×
Gefitinib
×
Clear all
NCT05834348
2025-03-30
DELINOR
Pfizer
Completed
5,279 enrolled
10 charts
NCT04179890
2023-05-25
UpSwinG
Boehringer Ingelheim
Completed
462 enrolled
23 charts